Ask & Answer

Do You Gain the Weight Back After Stopping a GLP-1?

Short answer: for most people, yes — and a large 2026 analysis of the actual published trials now shows roughly how much and how fast. Here's the real trajectory, not the anecdote.

By Reese Calloway · Health Claims Researcher

Five of the seven GLP-1-branded solutions in our own GLP-1 investigation are real prescription telehealth options — compounded or brand-name semaglutide and tirzepatide, dispensed by a licensed clinician. Every one of them treats an ongoing weight-loss plan, not a fixed course. What almost none of their marketing pages address head-on is what happens on the other side, if and when someone stops.

What the newest research actually found

In March 2026, researchers at the University of Cambridge's Institute of Metabolic Science published a systematic review and nonlinear meta-regression in eClinicalMedicine (part of The Lancet journal family), pooling data across 48 relevant studies, including six randomized controlled trials covering more than 3,200 participants. The question was simple: once someone stops a GLP-1 receptor agonist, what does the weight curve actually look like afterward?

The real numbers. At one year after stopping, the analysis found that roughly 60% of the weight lost during treatment had been regained on average. Modeling the longer-term trajectory, regain was estimated to plateau at around 75% of the weight originally lost. That's not everyone reverting to their exact starting weight — a meaningful minority of the loss tends to stick — but for most people, the majority of it comes back.

Why the weight comes back

Per the Cleveland Clinic, GLP-1 drugs work through several mechanisms at once: they slow how fast the stomach empties, increase feelings of fullness, and reduce appetite signaling in the brain. Those effects are tied to the drug being active in the body. When the medication stops, those appetite-suppressing effects fade — which is a physiological mechanism reversing, not a personal failure of willpower. That framing matters, because it's the same reason researchers increasingly describe obesity treatment with these drugs as a chronic-management model rather than a fixed course, similar to how blood pressure or cholesterol medication is typically discussed.

What this means if you're evaluating a GLP-1 telehealth plan

This isn't a reason to avoid GLP-1 medications — the same body of research these drugs are built on shows real average weight loss during active treatment, as detailed in our GLP-1 investigation. It is a reason to ask a specific, practical question before starting with any of the five real prescription options we compared: what does this program actually look like as a long-term plan, not just an eight- or twelve-week starting dose? A provider that can answer that clearly — maintenance dosing, cost at maintenance, what happens if you need to pause — is telling you more than one that only markets the starting phase.

The bottom line

The best current published evidence says most people regain a majority of the weight they lost within roughly a year or two of stopping a GLP-1 medication, with average regain leveling off around three-quarters of what was lost. Individual results vary — some people keep more of the loss than others — but no provider can honestly promise in advance which outcome you'll get. Plan around the real average, not the exception.

See how the five real prescription options in our GLP-1 comparison actually differ — pricing, medication, and the two supplement products that don't contain a GLP-1 drug at all.

Read the full GLP-1 investigation →

Sources

Not medical advice. Talk to a real clinician before starting or stopping any prescription medication. Questions about this piece? Email contact@healthyhealthsecrets.com. See also our About page and affiliate disclosure.